Zenas BioPharma, Inc. (ZBIO)
NASDAQ: ZBIO · Real-Time Price · USD
18.42
+0.81 (4.60%)
At close: Jun 9, 2026, 4:00 PM EDT
18.06
-0.36 (-1.95%)
After-hours: Jun 9, 2026, 4:21 PM EDT
Zenas BioPharma Market Cap
Zenas BioPharma has a market cap or net worth of $1.16 billion as of June 9, 2026. Its market cap has increased by 143.20% in one year.
Market Cap
1.16B
Enterprise Value
712.54M
1-Year Change
143.20%
Ranking
Category
Stock Price
$18.42
Market Cap Chart
Since the IPO on September 13, 2024, Zenas BioPharma's market cap has increased from $676.47M to $1.16B, an increase of 71.91%. That is a compound annual growth rate of 36.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 9, 2026 | 1.16B | -40.34% |
| Dec 31, 2025 | 1.95B | 469.46% |
| Dec 31, 2024 | 342.27M | -49.40% |
| Sep 13, 2024 | 676.47M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Precigen | 1.28B |
| MapLight Therapeutics | 1.27B |
| Avalyn Pharma | 1.13B |
| Hemab Therapeutics Holdings | 1.12B |
| Wave Life Sciences | 1.10B |
| MannKind | 1.05B |
| Aktis Oncology | 1.04B |
| Jade Biosciences | 1.01B |